| Room 1 (Chandelier 1) | |
|---|---|
| Time | Title |
| 8.30-9.20 |
Controversy 3The Ultimate Blood Battle: Is There Still a Role of Whole Blood Transfusion? |
| 9.20-9.50 |
Symposium 11Optimizing Coagulation Management: The Integration of 4F-PCC in VKA Reversal |
| 9.50-10.20 |
Break |
| 10.20-10.50 |
Symposium 12First-Line Polatuzumab for DLBCL: Evidence, Impact, and Future Directions |
| 10.50-11.20 |
Symposium 13A Challenging Post-HSCT Case: When to Consider CMVIG and IgM IVIG? |
| 11.20-12.00 |
Case discussion 2Challenging the Standards in the Hb Target of Thalassemia |
| 12.00-12.10 |
Close and thank youรศ.ดร.นพ.ชาตรี ชัยอดิศักดิ์โสภา |